Harvard Bioscience (HBIO)

• Market cap: $27.6M
• 1 day: -3.25%
• 5 days: 0.76%
• 1 month: 55.7%
• 3 months: 27.25%
• 6 months: 81.84%
• Year to date: -69.47%
• 1 year: -69.77%
• 5 years: -84.15%
• 10 years: -79.13%
• Sector: Healthcare
• Industry: Medical Instruments & Supplies

About: Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.

Employees: 355